• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/8

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

8 Cards in this Set

  • Front
  • Back
Chronic myelogenous
leukemia (CML), in its chronic phase,
presents with
Chronic myelogenous
leukemia (CML), in its chronic phase,
presents with constitutional symptoms along
with abdominal fullness due to splenomegaly.
Diagnosis is most common in the fourth to
sixth decades of life, and irradiation increases
the risk of developing CML. Because it is a
proliferation of mature myeloid cells, peripheral
smear should show predominant leukocytosis
with cells in all stages of maturation. Definitive
diagnosis relies on identification of the
Philadelphia chromosome or the bcr-abl fusion
product. However, approximately 5% of
patients have atypical CML without presence
of bcr-abl and show a poor response to therapy.
Diagnosis is most common in
Diagnosis is most common in the fourth to
sixth decades of life, and i
what is increases
the risk of developing CML
rradiation increases
the risk of developing CML.
smear should show
Because it is a
proliferation of mature myeloid cells, peripheral
smear should show predominant leukocytosis
with cells in all stages of maturation.
Definitive
diagnosis
Definitive
diagnosis relies on identification of the
Philadelphia chromosome or the bcr-abl fusion
product. However, approximately 5% of
patients have atypical CML without presence
of bcr-abl and show a poor response to therapy.
what % of patients have atypical CML without presence
of bcr-abl and show a poor response to therapy.
However, approximately 5% of
patients have atypical CML without presence
of bcr-abl and show a poor response to therapy.
bone marrow,
. CML
may show hypercellularity of the bone marrow,
as well as differentiated cells rather than blasts.
A bone marrow biopsy will not, however, differentiate
the type of leukemia. The diagnosis
of CML depends on cytogenetics.
The diagnosis
of CML depends on
The diagnosis
of CML depends on cytogenetics.